Our ambition is to unlock the potential of nucleic acid therapeutics by leveraging the drug delivery capabilities of our innovative product engine. PepGen's initial focus is on the application of this technology to the efficacious delivery of antisense oligonucleotides, and we are advancing novel conjugate therapeutics to the clinic. PepGen’s ambition is to harness the power of peptide conjugation technologies in order to ad...
Our ambition is to unlock the potential of nucleic acid therapeutics by leveraging the drug delivery capabilities of our innovative product engine. PepGen's initial focus is on the application of this technology to the efficacious delivery of antisense oligonucleotides, and we are advancing novel conjugate therapeutics to the clinic. PepGen’s ambition is to harness the power of peptide conjugation technologies in order to address the delivery challenge associated with nucleic acid therapeutics and thus realise the clinical potential of these transformative therapeutics.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.